Detalhe da pesquisa
1.
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.
Blood;
140(22): 2403-2407, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36150168
2.
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia.
Haematologica;
109(2): 646-651, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37646668
3.
T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.
Haematologica;
107(4): 1000-1003, 2022 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35045694
4.
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
Leukemia;
36(2): 476-481, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34564699
5.
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.
EBioMedicine;
74: 103705, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34861491